Drug Discovery and Assets Innovation Lab, DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8565, Japan.
Int J Oncol. 2018 Jan;52(1):19-37. doi: 10.3892/ijo.2017.4203. Epub 2017 Nov 10.
Cancer is one of the most important healthcare matters, with the worst prognosis but the best possibilities for scientific development. It is likely to increase in the future and cause global havoc designating it as an epidemic. Cancer development requires urgent intervention. Past few decades have witnessed extensive research to challenge carcinogenesis. Treatment involving synthetic discipline is often associated with severe adverse effects, or even worsened prognosis. Accordingly, newer economic and patient friendly molecules are warranted. Many natural substances have proved their potential so far. Cucurbitacin B against cancer and other diseases has achieved towering popularity among the researchers around the world, as detailed in the below sections with summarized tables. In line with the fascinating role of cucurbitacin B against various types of cancers, through various molecular signaling pathways, it is justifiable to propose cucurbitacin B as a mainline chemotherapy before the onset and after the diagnosis of cancer.
癌症是最重要的医疗保健问题之一,其预后最差,但具有最好的科学发展可能性。未来它可能会增加,并造成全球混乱,将其指定为一种流行病。癌症的发展需要紧急干预。过去几十年见证了广泛的研究以挑战致癌作用。涉及合成学科的治疗方法通常与严重的不良反应相关,甚至使预后恶化。因此,需要更经济实惠且对患者友好的新型分子。到目前为止,许多天然物质已经证明了它们的潜力。在下面的章节中,通过总结表详细说明了葫芦素 B 对癌症和其他疾病的作用,使其在全球研究人员中获得了极高的人气。鉴于葫芦素 B 对各种类型癌症的迷人作用,通过各种分子信号通路,可以合理地将葫芦素 B 作为癌症发生前和诊断后的一线化疗药物。